Screener
Sarepta Therapeutics, Inc. SRPT Collaboration revenue
Collaboration revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Products, net | $328,689 | $513,123 | $659,204 | $1,124,646 |
| Collaboration and other | 72,562 | 97,968 | 472,850 | 231,301 |
| Total revenues | 401,251 | 611,091 | 1,132,054 | 1,355,947 |
| Cost and expenses: | ||||
| Cost of sales (excluding amortization of in-licensed rights) | 149,385 | 152,558 | 258,153 | 290,122 |
| Research and development | 91,258 | 204,392 | 245,218 | 977,840 |
| Selling, general and administrative | 107,600 | 137,897 | 216,551 | 271,526 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s collaboration revenue?
- Sarepta Therapeutics, Inc. (SRPT) reported collaboration revenue of $72.56M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s collaboration revenue changed year-over-year?
- Sarepta Therapeutics, Inc.'s collaboration revenue decreased by 25.9% year-over-year, from $97.97M to $72.56M.
- What does collaboration revenue mean?
- Collaboration revenue
Ask your AI about Sarepta Therapeutics, Inc.'s collaboration revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude